COVID-19 has shown the power of clinical trials. It took less than 300 days for one vaccine to go from being an idea in a lab to be ready for administering to the general public. The question now is how we can accelerate clinical trials for other diseases, at a time when the healthcare industry is stretched and doesn’t have the capacity to run patient research at the speed or scale that’s needed.
Here, we caught up with Dr Matt Wilson, Founder and CEO of research automation platform, uMed, who is on a mission to help more healthcare providers and their patients take part in clinical studies.